Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Corning | Michelle L. Gullo | Senior Vice President & CHRO | Sale of securities on an exchange or to another person at price $ 152.29 per share. | 04 Sep 2026 | 9,874 | 9,384 (0%) | 0% | 152.3 | 1,503,713 | Common Stock |
| TTM Tech Inc | Edwin Roks | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.33 per share. | 02 Sep 2026 | 5,331 | 59,483 (0%) | 0% | 115.3 | 614,824 | Common Stock |
| Methode Electronics Inc | Stacie Schulz | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 18.10 per share. | 02 Sep 2026 | 1,649 | 9,811 (0%) | 0% | 18.1 | 29,847 | Common Stock |
| Bel Fuse Inc (Class B) | Vincent Vellucci | Director | Sale of securities on an exchange or to another person at price $ 243.61 per share. | 02 Sep 2026 | 393 | 8,434 (0%) | 0% | 243.6 | 95,739 | Class B Common Stock |
| Vicor Corp | Philip Davies | Director, Corp. VP-Global Sales & Mktg. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.61 per share. | 01 Sep 2026 | 3,073 | 4,993 (0%) | 0% | 41.6 | 127,868 | Common Stock |
| Vicor Corp | Philip Davies | Director, Corp. VP-Global Sales & Mktg. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 3,073 | 856 | - | - | Non Qualified Stock Option | |
| Vicor Corp | Philip Davies | Director, Corp. VP-Global Sales & Mktg. | Sale of securities on an exchange or to another person at price $ 176.59 per share. | 01 Sep 2026 | 1,173 | 3,820 (0%) | 0% | 176.6 | 207,143 | Common Stock |
| Vicor Corp | Philip Davies | Director, Corp. VP-Global Sales & Mktg. | Sale of securities on an exchange or to another person at price $ 177.63 per share. | 01 Sep 2026 | 1,100 | 2,720 (0%) | 0% | 177.6 | 195,394 | Common Stock |
| Vicor Corp | Philip Davies | Director, Corp. VP-Global Sales & Mktg. | Sale of securities on an exchange or to another person at price $ 178.66 per share. | 01 Sep 2026 | 700 | 2,020 (0%) | 0% | 178.7 | 125,062 | Common Stock |
| Vicor Corp | Philip Davies | Director, Corp. VP-Global Sales & Mktg. | Sale of securities on an exchange or to another person at price $ 184.85 per share. | 01 Sep 2026 | 100 | 1,920 (0%) | 0% | 184.9 | 18,485 | Common Stock |
| RxSight Inc | Mark Wilterding | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2026 | 20,441 | 122,646 | - | - | Restricted Stock Unit | |
| RxSight Inc | Mark Wilterding | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2026 | 20,441 | 32,814 | - | - | Common Stock | |
| RxSight Inc | Ron Kurtz | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2026 | 13,425 | 67,120 | - | - | Restricted Stock Unit | |
| RxSight Inc | Ron Kurtz | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2026 | 13,425 | 76,875 | - | - | Common Stock | |
| RxSight Inc | Mark Wilterding | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.96 per share. | 31 Aug 2026 | 7,765 | 25,049 | - | 7.0 | 54,044 | Common Stock |
| RxSight Inc | Eric Weinberg | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2026 | 5,370 | 202,389 | - | - | Common Stock | |
| RxSight Inc | Eric Weinberg | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2026 | 5,370 | 26,848 | - | - | Restricted Stock Unit | |
| RxSight Inc | Ilya Goldshleger | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2026 | 5,370 | 26,848 | - | - | Restricted Stock Unit | |
| RxSight Inc | Ilya Goldshleger | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2026 | 5,370 | 83,550 | - | - | Common Stock | |
| RxSight Inc | Ron Kurtz | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.96 per share. | 31 Aug 2026 | 5,100 | 71,775 | - | 7.0 | 35,496 | Common Stock |
| RxSight Inc | Eric Weinberg | See remarks | Sale of securities on an exchange or to another person at price $ 6.96 per share. | 31 Aug 2026 | 2,041 | 200,348 | - | 7.0 | 14,205 | Common Stock |
| RxSight Inc | Ilya Goldshleger | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.96 per share. | 31 Aug 2026 | 2,041 | 81,509 | - | 7.0 | 14,205 | Common Stock |
| Corning | Lewis A. Steverson | Vice Chairman, EVP and CLAO | Sale of securities on an exchange or to another person at price $ 151.29 per share. | 28 Aug 2026 | 13,100 | 15,052 (0%) | 0% | 151.3 | 1,981,929 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.